Clinical laboratory professionals may see more health systems consolidating laboratory purchasing with broader hospital supply-chain operations as Medline continues to expand its presence in the clinical laboratory market.
The medical-surgical products and supply-chain company announced that it has expanded its long-standing Prime Vendor agreement with Springfield, Mo.-based CoxHealth to include laboratory products and distribution services. CoxHealth operates six hospitals and more than 100 locations, primarily in southwest Missouri, with a presence in northwest Arkansas.
The agreement builds on a 13-year relationship between the organizations. CoxHealth's laboratories will gain access to Medline's portfolio of laboratory products as well as its distribution network, which the organizations say will help streamline deliveries and improve operational efficiency.
“As Medline continues to expand its presence and capabilities within the laboratory market, we are excited to strengthen our partnership and leverage their proven distribution expertise,” said John Black, chief supply chain officer at CoxHealth.
More health systems consolidate lab purchasing
The CoxHealth agreement follows several similar deals and suggests Medline is making a concerted push to expand its clinical laboratory distribution business.
In May, Baton Rouge-based Woman's Hospital expanded its Medline agreement to include laboratory products, with the organizations citing more efficient ordering, improved inventory visibility, and reliable delivery. In June, Memorial Hospital Biloxi added laboratory distribution when its health system renewed its systemwide agreement with Medline.
That pattern was already apparent in 2025. UC Health expanded its existing Medline relationship to cover its laboratory locations, while Beacon Health System signed a multi-year laboratory agreement covering 11 hospitals. Beacon specifically cited product standardization, improved efficiency, cost management, and supply-chain resilience as reasons for consolidating multiple vendors into one strategic partnership.
For clinical laboratory professionals, these agreements demonstrate how laboratory purchasing and inventory management may increasingly be incorporated into enterprise-wide health system supply-chain strategies. Such consolidation could give health systems greater leverage over costs and product standardization while potentially changing how much autonomy individual laboratories have over purchasing and vendor relationships.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
